Factor X Level Test in Pakistan at Chughtai Lab

Understanding the Factor X Level Test at Chughtai Lab

The Factor X Level test is a highly specialized coagulation assay that measures the activity or concentration of Factor X, also known as the Stuart-Prower factor, in the blood. Factor X is a crucial vitamin K-dependent glycoprotein synthesized in the liver. It occupies a central position in the coagulation cascade, serving as the very first enzyme in the common pathway where both the intrinsic and extrinsic coagulation pathways converge. When activated to Factor Xa, it forms the prothrombinase complex alongside cofactor Va, calcium ions, and phospholipid surfaces. This complex is responsible for cleaving prothrombin (Factor II) into active thrombin (Factor IIa), which subsequently converts soluble fibrinogen into insoluble fibrin strands, forming a stable blood clot to arrest bleeding.

At Chughtai Lab, this test is performed using state-of-the-art automated coagulation analyzers that utilize advanced chromogenic or clot-based assays to ensure the highest degree of diagnostic precision. Evaluating Factor X activity is clinically vital for diagnosing rare congenital bleeding disorders, assessing acquired bleeding diatheses, investigating unexplained prolongations in routine coagulation screens, and managing complex hematological conditions. By measuring the precise functional capacity of this clotting factor, hematologists and primary care physicians can make informed decisions regarding patient care, surgical clearance, and therapeutic interventions.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is paramount to ensure the clinical accuracy of coagulation assays, as pre-analytical variables can significantly influence the test results. Patients undergoing a Factor X Level test at Chughtai Lab should observe the following preparation guidelines:

• Medication Review: Inform your prescribing physician and the laboratory staff of all medications, over-the-counter drugs, and herbal supplements you are currently taking. Anticoagulants such as warfarin, heparin, low-molecular-weight heparin (LMWH), and direct oral anticoagulants (DOACs) like rivaroxaban or apixaban can directly interfere with Factor X assays. Your physician may advise temporarily discontinuing these medications prior to the test, but do not stop any medication without explicit medical guidance.
• Fasting Requirements: Strict fasting is generally not required for a Factor X Level test. However, patients are advised to avoid consuming high-fat or greasy meals for at least 4 to 6 hours before the blood draw, as lipemic plasma can interfere with the optical detection systems used in automated coagulation analyzers.
• Hydration: Stay adequately hydrated by drinking plenty of water before the procedure, as this makes venipuncture easier and helps maintain normal plasma volume.
• Avoid Physical Stress: Avoid strenuous physical exercise and acute physical stress immediately before the test, as extreme physical exertion can transiently alter clotting factor levels.

During the Procedure

The collection of a blood sample for a Factor X Level test is a standard venipuncture procedure executed by highly trained phlebotomists at Chughtai Lab. The process involves the following steps:

• Patient Identification and Positioning: The phlebotomist will verify your identity using standard protocols. You will be seated comfortably, and your arm will be positioned to expose the antecubital fossa (the inner bend of the elbow).
• Site Selection and Cleansing: A suitable vein will be selected. The skin over the selected vein will be thoroughly cleansed with an antiseptic solution (typically 70% isopropyl alcohol) and allowed to air dry to prevent hemolysis or contamination.
• Tourniquet Application: A tourniquet will be applied a few inches above the puncture site to make the vein more visible and accessible. The tourniquet will not be left on for more than one minute to prevent hemoconcentration.
• Venipuncture: A sterile, single-use needle will be gently inserted into the vein. For coagulation testing, blood is collected into a light blue-top tube containing 3.2% buffered sodium citrate. This anticoagulant binds calcium in the blood, preventing clotting during transport and processing.
• Tube Filling: The tube must be filled completely to the designated mark to ensure the precise 9:1 ratio of blood to liquid anticoagulant. An incorrect ratio can lead to falsely prolonged or shortened clotting times.
• Post-Collection Care: Once the tube is filled, the needle is removed, and immediate, gentle pressure is applied to the puncture site with a sterile gauze pad to prevent hematoma formation. The tube is gently inverted 3 to 4 times to mix the blood thoroughly with the sodium citrate. A small bandage will be applied over the site.
• Safety and Comfort: The entire process takes less than five minutes. You may feel a brief pinch as the needle enters the skin. The procedure is highly safe, with minimal risks such as minor bruising or localized soreness at the puncture site.

When is a Factor X Level Test Performed?

Investigating Unexplained Bleeding Episodes

Physicians frequently request a Factor X Level test when a patient presents with recurrent, unexplained, or severe bleeding episodes. These symptoms may manifest as frequent nosebleeds (epistaxis), easy bruising (ecchymosis), prolonged bleeding from minor cuts, heavy menstrual bleeding (menorrhagia), or bleeding into joints (hemarthrosis) and muscles. By quantifying Factor X activity, clinicians can determine if a deficiency in this specific clotting factor is the underlying cause of the bleeding diathesis, allowing for targeted therapeutic management.

Evaluating Abnormal Coagulation Screening Tests

Routine screening tests like Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) are often performed as part of a pre-operative workup or general health evaluation. Because Factor X sits at the junction of both the intrinsic and extrinsic pathways, a deficiency or inhibitor of Factor X will characteristically cause a prolongation of both PT and aPTT. When both of these screening tests are abnormally prolonged, a Factor X assay is indicated as a reflex or confirmatory test to isolate the specific defect in the common pathway.

Diagnosing Congenital Factor X Deficiency

Congenital Factor X deficiency is an extremely rare, autosomal recessive bleeding disorder. It affects approximately one in a million individuals worldwide. The severity of symptoms correlates with the level of functional Factor X in the blood. Severe deficiencies can lead to life-threatening bleeding episodes in early infancy, such as umbilical cord bleeding, intracranial hemorrhage, or gastrointestinal bleeding. Mild cases may only be discovered later in life following trauma or surgical procedures. Quantifying Factor X levels is essential for diagnosing this genetic condition and formulating a lifelong management plan.

Assessing Acquired Factor X Deficiency

Acquired Factor X deficiency is more common than the congenital form and is frequently associated with specific underlying medical conditions. A classic clinical association is systemic AL amyloidosis, where the amyloid fibrils circulating in the blood or deposited in tissues selectively adsorb Factor X, rapidly clearing it from the circulation and causing a severe, acquired deficiency. Other causes include severe liver disease (which impairs the synthesis of all vitamin K-dependent factors), severe vitamin K deficiency, and the use of vitamin K antagonists like warfarin. Identifying an acquired deficiency helps guide treatment of the primary disease and management of bleeding risks.

Pre-Operative Evaluation in High-Risk Patients

For patients with a personal or family history of bleeding disorders, or those undergoing major surgical procedures with a high risk of bleeding (such as neurosurgery, cardiac surgery, or orthopedic procedures), a Factor X Level test may be performed pre-operatively. Ensuring adequate levels of Factor X is critical to prevent catastrophic intraoperative and postoperative hemorrhages. If a deficiency is identified, hematologists can arrange for prophylactic replacement therapy using prothrombin complex concentrates (PCCs) or fresh frozen plasma (FFP) prior to the surgical incision.

What Does a Factor X Level Test Detect?

The Factor X Level test is highly sensitive and specific, capable of detecting a wide range of congenital, acquired, and therapeutic alterations in the coagulation system. Specifically, this test can detect and assist in the evaluation of:

• Severe congenital Factor X deficiency (activity levels typically less than 1% of normal).
• Moderate congenital Factor X deficiency (activity levels between 1% and 5% of normal).
• Mild congenital Factor X deficiency (activity levels between 6% and 30% of normal).
• Acquired Factor X deficiency secondary to systemic AL amyloidosis.
• Vitamin K deficiency, which impairs the gamma-carboxylation required for Factor X activation.
• Impaired hepatic synthesis of Factor X due to end-stage liver disease, cirrhosis, or acute liver failure.
• The therapeutic effect of vitamin K antagonists (such as warfarin), which systematically lower functional Factor X levels.
• The presence of specific Factor X inhibitors (autoantibodies), which neutralize Factor X activity.
• The presence of non-specific inhibitors, such as lupus anticoagulants, which can interfere with certain phospholipid-dependent Factor X assays.
• Consumption of clotting factors, including Factor X, during Disseminated Intravascular Coagulation (DIC).
• Dilutional coagulopathy following massive blood transfusions without adequate plasma replacement.
• The impact of direct oral anticoagulants (DOACs) that target Factor Xa, such as rivaroxaban, apixaban, and edoxaban.
• Malabsorption syndromes (e.g., celiac disease, Crohn’s disease) leading to secondary vitamin K deficiency and subsequent low Factor X.
• Neonatal physiological deficiency, as newborns naturally have lower levels of vitamin K-dependent clotting factors.
• The efficacy of replacement therapies, such as the administration of fresh frozen plasma (FFP) or prothrombin complex concentrates (PCC).
• Subclinical bleeding risks in patients preparing for invasive dental or surgical procedures.
• The underlying cause of recurrent joint bleeding (hemarthrosis) in patients without hemophilia A or B.
• The etiology of severe, unexplained postpartum hemorrhage.
• The cause of prolonged bleeding times in patients with normal platelet counts and normal von Willebrand factor levels.
• Fluctuations in clotting factor levels during pregnancy, where certain factors may rise, though Factor X must be carefully monitored if a pre-existing deficiency exists.

Turnaround Time and Report Access at Chughtai Lab

Chughtai Lab is committed to delivering highly accurate diagnostic results with an efficient turnaround time. Because the Factor X Level test is a specialized coagulation assay requiring precise laboratory conditions and expert interpretation, the turnaround time is typically within 24 to 48 hours from the time of sample collection. This timeline ensures that the plasma is processed, analyzed, and reviewed by a consultant hematologist to guarantee clinical accuracy.

Patients and referring physicians can access test reports seamlessly through Chughtai Lab’s advanced digital infrastructure. Once the report is finalized, an automated SMS notification is sent to the patient’s registered mobile number containing a direct link to download the report. Reports can also be accessed and downloaded online via the official Chughtai Lab website portal or through the user-friendly Chughtai Lab Mobile App. Physical copies of the report can be collected from any Chughtai Lab collection center or delivered directly to the patient’s home through their dedicated courier service.

Factor X Level Findings Overview

The following table outlines the typical parameters evaluated during a Factor X Level test, along with normal reference ranges and potential clinical implications of abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Factor X Functional Activity	70% to 140% of normal activity	< 70% (Deficiency: congenital, liver disease, vitamin K deficiency, amyloidosis, or anticoagulant therapy)
Prothrombin Time (PT)	11 to 13.5 seconds (may vary by lab)	Prolonged (indicates defect in extrinsic or common pathway, including Factor X deficiency)
Activated Partial Thromboplastin Time (aPTT)	25 to 35 seconds (may vary by lab)	Prolonged (indicates defect in intrinsic or common pathway, including Factor X deficiency)
Thrombin Time (TT)	Normal (12 to 14 seconds)	Normal in isolated Factor X deficiency (helps rule out fibrinogen abnormalities or heparin contamination)
Mixing Studies (with normal plasma)	Correction of prolonged PT/aPTT	Failure to correct (suggests the presence of a Factor X inhibitor or lupus anticoagulant)
Factor X Antigen Level	70% to 140% (matches functional activity)	Decreased in Type I deficiency (quantitative defect); Normal but low activity in Type II deficiency (qualitative defect)
Response to Vitamin K Therapy	Not applicable (baseline)	Normalization of Factor X levels (confirms nutritional vitamin K deficiency or malabsorption)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Factor X Level?

• Experienced Healthcare Professionals: Chughtai Lab features a team of highly qualified consultant pathologists and hematologists who oversee all coagulation testing and provide expert clinical interpretations.
• Patient-Focused Care: The laboratory staff is dedicated to ensuring a comfortable, stress-free, and professional experience for every patient during sample collection.
• Quality Diagnostic Services: Chughtai Lab adheres to strict international quality control standards and is ISO 15189 certified, ensuring the highest level of diagnostic accuracy.
• Professional Reporting: Reports are detailed, clear, and structured to provide clinicians with the precise quantitative data needed for clinical decision-making.
• Modern Diagnostic Approach: The laboratory utilizes advanced, fully automated coagulation analyzers that minimize human error and enhance testing efficiency.
• Comfortable Environment: All collection centers across Pakistan are designed to provide a clean, hygienic, and welcoming environment for patients of all ages.
• Convenient Location: With an extensive network of hundreds of collection centers across Pakistan, finding a Chughtai Lab facility near you is incredibly easy.
• Commitment to Accurate Diagnosis: From sample collection in sodium citrate tubes to temperature-controlled transport and precise analysis, Chughtai Lab maintains an unbroken chain of quality to deliver results you can trust.